Hideho Okada

MD, PhD

San Francisco, CA USA

UCSF Benioff Children's Hospital

Hideo_Okada.jpg

About

Professor of Neurological Surgery, Surgery and Immunology

University of California San Francisco

As a physician scientist, I have been dedicated to brain tumor immunology and development of effective immunotherapy for brain tumors for over 20 years. My team was one of very first to discover cytotoxic T lymphocyte (CTL) epitopes in glioma-associated and glioma-specific neoantigens, and found critical roles for the integrin receptor known as very late activation antigen (VLA)-4 in facilitating entry of CTLs to the brain tumor site. I have translated these discoveries into novel vaccine and immune-gene therapy clinical studies in both adult and pediatric brain tumor patients. I am a member in the American Society for Clinical Investigation (2010-present), an honored society for physicians who promote laboratory science to the clinic. My current national and international leadership roles include: chair of the immunotherapy subgroup at the NCI-sponsored Adult Brain Tumor Consortium; a Steering Committee member of the Cancer Immunology Working Group in the American Association for Cancer Research (AACR); a co-chair for Education Day at 2015 the Society for Neuro-Oncology annual meeting; and an Organizing Committee member for the 2015 Annual Meeting of the AACR.